These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1620660)

  • 1. Peripheral factors in the mediation of cholecystokinin-induced satiety as assessed by comparative potencies of cholecystokinin antagonists.
    Murphy RB; Smith GP; Schneider LH; Gibbs J
    Peptides; 1992; 13(1):77-81. PubMed ID: 1620660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
    Corp ES; Curcio M; Gibbs J; Smith GP
    Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of three non-peptide cholecystokinin antagonists (devazepide, lorglumide and loxiglumide) in human isolated alimentary muscle and guinea-pig ileum.
    D'Amato M; Stamford IF; Bennett A
    Br J Pharmacol; 1991 Feb; 102(2):391-5. PubMed ID: 2015421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats.
    Makovec F; Bani M; Chistè R; Revel L; Rovati LC; Setnikar I
    Regul Pept; 1986 Dec; 16(3-4):281-90. PubMed ID: 3562900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
    Dourish CT; Rycroft W; Iversen SD
    Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats].
    Wang SX
    Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):443-6. PubMed ID: 8010038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological examination of cholecystokinin (CCK-8)-induced contractile activity in the rat isolated pylorus.
    Murphy RB; Smith GP; Gibbs J
    Peptides; 1987; 8(1):127-34. PubMed ID: 3033618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic CCK8 analogs with antagonist activity on pancreatic receptors: in vivo study in the rat, compared to non-peptidic antagonists.
    Nagain C; Galas MC; Lignon MF; Rodriguez M; Martinez J; Rozé C
    Pancreas; 1991 May; 6(3):275-81. PubMed ID: 1713671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proglumide fails to increase food intake after an ingested preload.
    Schneider LH; Gibbs J; Smith GP
    Peptides; 1986; 7(1):135-40. PubMed ID: 3714531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin-A receptor mediation of food intake in cats.
    Bado A; Durieux C; Moizo L; Roques BP; Lewin MJ
    Am J Physiol; 1991 Apr; 260(4 Pt 2):R693-7. PubMed ID: 2012242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
    Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
    Br J Pharmacol; 1992 May; 106(1):61-6. PubMed ID: 1504732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.
    Vasar E; Lang A; Harro J; Bourin M; Bradwejn J
    Neuropharmacology; 1994 Jun; 33(6):729-35. PubMed ID: 7936110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pylorus in mediating cholecystokinin-stimulated satiety in the Zucker rat.
    Berk T; Crochelt RF; Peikin SR
    Dig Dis Sci; 1986 May; 31(5):502-5. PubMed ID: 3698766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of two new cholecystokinin antagonists on gallbladder emptying in opossums.
    Hanyu N; Dodds WJ; Layman RD; Hogan WJ; Colton DG
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G258-64. PubMed ID: 1996645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of satiety by a cholecystokinin antagonist is independent of gastric emptying.
    Collins SM; Weingarten HP
    Peptides; 1984; 5(3):481-4. PubMed ID: 6089141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new simple mouse model for the in vivo evaluation of cholecystokinin (CCK) antagonists: comparative potencies and durations of action of nonpeptide antagonists.
    Lotti VJ; Cerino DJ; Kling PJ; Change RS
    Life Sci; 1986 Nov; 39(18):1631-8. PubMed ID: 3773639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and sustained satiety actions of a cholecystokinin octapeptide analogue.
    Moran TH; Sawyer TK; Seeb DH; Ameglio PJ; Lombard MA; McHugh PR
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):286S-290S. PubMed ID: 1728841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.